NCT00166478View on ClinicalTrials.gov

Exisulind Prior to Radical Prostatectomy

PHASE2CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

Prostatic Neoplasms

Interventions

DRUG

Exisulind Therapy

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER